These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3942995)

  • 1. Oral contraceptive use has no adverse effect on the prognosis of breast cancer.
    Rosner D; Lane WW
    Cancer; 1986 Feb; 57(3):591-6. PubMed ID: 3942995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and prognosis of breast cancer in women aged 35 to 50.
    Rosner DH; Joy JV; Lane WW
    J Surg Oncol; 1985 Sep; 30(1):52-9. PubMed ID: 4079419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of oral contraceptives on the prognosis of breast cancer in young women.
    Rosner D; Lane WW; Perez Brett R
    Cancer; 1985 Apr; 55(7):1556-62. PubMed ID: 3978550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and the prognosis of breast cancer.
    Schönborn I; Nischan P; Ebeling K
    Breast Cancer Res Treat; 1994; 30(3):283-92. PubMed ID: 7981446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in breast cancer and age at start of oral contraceptive usage.
    Ranstam J; Olsson H; Garne JP; Aspegren K; Janzon L
    Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer.
    Holmberg L; Lund E; Bergström R; Adami HO; Meirik O
    Eur J Cancer; 1994; 30A(3):351-4. PubMed ID: 8204358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group.
    Sauerbrei W; Blettner M; Schmoor C; Bojar H; Schumacher M
    Eur J Cancer; 1998 Aug; 34(9):1348-51. PubMed ID: 9849415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and breast cancer.
    Kalache A; McPherson K; Barltrop K; Vessey MP
    Br J Hosp Med; 1983 Oct; 30(4):278-83. PubMed ID: 6640197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
    Huzell L; Persson M; Simonsson M; Markkula A; Ingvar C; Rose C; Jernström H
    Breast Cancer Res Treat; 2015 Jan; 149(2):505-15. PubMed ID: 25556354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
    Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
    Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
    Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.